Schonfeld Strategic Advisors LLC - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 51 filers reported holding LEAP THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$17,238
-27.9%
50,700
-4.5%
0.00%
Q4 2022$23,895
-48.1%
53,100
+1.9%
0.00%
Q3 2022$46,000
-23.3%
52,100
+0.2%
0.00%
-100.0%
Q2 2022$60,000
-31.0%
52,000
+5.7%
0.00%0.0%
Q1 2022$87,000
-24.3%
49,200
+39.4%
0.00%0.0%
Q4 2021$115,000
-19.0%
35,3000.0%0.00%0.0%
Q3 2021$142,000
-91.5%
35,300
-95.6%
0.00%
-95.5%
Q2 2020$1,670,000
+1755.6%
798,676
+894.4%
0.02%
+1000.0%
Q4 2019$90,0000.0%80,319
+4.3%
0.00%
-33.3%
Q3 2019$90,00077,0190.00%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
M28 Capital Management LP 2,664,400$2,345,0002.45%
Key Client Fiduciary Advisors, LLC 1,120,943$986,0000.89%
Knott David M Jr 900,000$792,0000.33%
ACT CAPITAL MANAGEMENT, LLC 265,000$233,0000.32%
Perceptive Advisors 7,472,148$6,575,0000.19%
Tri Locum Partners LP 711,798$626,0000.17%
683 Capital Management, LLC 2,265,000$1,993,0000.15%
Artal Group S.A. 4,000,000$3,520,0000.15%
TANG CAPITAL MANAGEMENT LLC 1,250,000$1,100,0000.14%
HealthCor Management, L.P. 1,066,689$939,0000.12%
View complete list of LEAP THERAPEUTICS INC shareholders